spinout
Illumina to Spin off Grail by Issuing Shares to Investors, Will Keep 14.5 Percent
Illumina shareholders will receive one share of Grail for every six shares of Illumina stock, with cash issued in lieu of fractional shares.
Tagomics Raises £6.7M in Private Funding Round
The University of Birmingham spinout will use the funding to support R&D for its multiomic platform for finding biomarkers for cancer and other diseases.
Hackensack Meridian Research Institute Spinout EValuate Diagnostics Gets $1M in Venture Funding
The firm intends to market a diagnostic platform that captures extracellular vesicles for the early detection of tumors and other diseases.
Claris GenomiX Seeks Commercialization Partners for Cancer Subtyping Tests, Starting With CRC
Premium
The University of Notre Dame spinout has developed molecular subtyping tests for colorectal and other cancers, and seeks partners to bring them to the clinic.
In addition to proving clinical utility, the startup will have to navigate issues of regulatory strategy, sequencing technology, and additional indications.
May 20, 2022
Feb 3, 2021
Jan 29, 2020
IDbyDNA Raises $20M in Series B Financing
Dec 10, 2019
Enzo Biochem Fiscal Q1 Revenues Down 5 Percent
Sep 11, 2019
Feb 20, 2018
Siemens Healthineers IPO Planned for H1 2018
Mar 20, 2017
EKF Diagnostics Plans Potential Split of Business
Sep 30, 2016